BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9140985)

  • 21. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
    Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
    Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diversity of basement membrane collagen: elucidation of the Goodpasture's epitope.
    Crouch EC
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):99-100. PubMed ID: 1716446
    [No Abstract]   [Full Text] [Related]  

  • 23. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen.
    Wieslander J; Barr JF; Butkowski RJ; Edwards SJ; Bygren P; Heinegård D; Hudson BG
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3838-42. PubMed ID: 6328527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial orientation and distribution of antigens within human glomerular basement membrane.
    Fish AJ; Carmody KM; Michael AF
    J Lab Clin Med; 1979 Sep; 94(3):447-57. PubMed ID: 89178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of Goodpasture antigens within various human basement membranes.
    Weber M; Pullig O; Köhler H
    Nephrol Dial Transplant; 1990; 5(2):87-93. PubMed ID: 2113218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen.
    Borza DB; Chedid MF; Colon S; Lager DJ; Leung N; Fervenza FC
    Am J Kidney Dis; 2005 Feb; 45(2):397-406. PubMed ID: 15685519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.
    Hellmark T; Johansson C; Wieslander J
    Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid assay for circulating anti-glomerular basement membrane antibodies in Goodpasture syndrome.
    Saxena R; Isaksson B; Bygren P; Wieslander J
    J Immunol Methods; 1989 Mar; 118(1):73-8. PubMed ID: 2647855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting.
    Derry CJ; Pusey CD
    Nephrol Dial Transplant; 1994; 9(4):355-61. PubMed ID: 8084446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis.
    Derry CJ; Pickering M; Baker C; Pusey CD
    Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Goodpasture syndrome. Progress in immunopathogenesis, diagnosis and therapy].
    Weber M; Marx M; Merkel F
    Internist (Berl); 1995 Mar; 36(3):227-35. PubMed ID: 7737815
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of Goodpasture target antigens in basement membranes of human glomeruli, lung, and placenta.
    Weber M; Köhler H; Manns M; Baum HP; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1987 Feb; 67(2):262-9. PubMed ID: 3608225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of Goodpasture syndrome].
    Kuhn M; Gartmann J; Hartmann G
    Dtsch Med Wochenschr; 1985 Feb; 110(5):183-4. PubMed ID: 3881240
    [No Abstract]   [Full Text] [Related]  

  • 34. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-type IV collagen antibodies in Goodpasture syndrome.
    Johansson C; Hellmark T; Wieslander J
    Contrib Nephrol; 1994; 107():188-93. PubMed ID: 8004967
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
    van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of bovine nephritogenic antigen that induces anti-GBM nephritis in rats and its similarity to the Goodpasture antigen.
    Sado Y; Kagawa M; Naito I; Okigaki T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):345-51. PubMed ID: 1722595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The case of the two disparate diseases: a medical mystery. Part 2.
    Helderman JH
    Am J Nephrol; 1991; 11(3):238-48. PubMed ID: 1962670
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
    Thorner PS; Baumal R; Eddy A; Marrano P
    Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of the Goodpasture antigen by immunoelectron microscopy.
    Sisson S; Dysart NK; Fish AJ; Vernier RL
    Clin Immunol Immunopathol; 1982 May; 23(2):414-29. PubMed ID: 7049468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.